# Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications

**Authors:** Yinan Liu, Yanru Li

PMC · DOI: 10.3389/fphar.2026.1694895 · Frontiers in Pharmacology · 2026-02-13

## TL;DR

This review explores how iron and copper-related cell death mechanisms, ferroptosis and cuproptosis, interact in head and neck cancer, offering new therapeutic strategies.

## Contribution

The paper introduces a systematic analysis of interconnected ferroptosis and cuproptosis mechanisms in HNSCC, highlighting dual-targeting therapeutic potential.

## Key findings

- Ferroptosis and cuproptosis are interconnected and influence HNSCC progression and treatment response.
- Dual-targeting strategies may offer clinical advantages for HNSCC therapy.
- Biomarkers from these pathways have diagnostic and therapeutic significance.

## Abstract

Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly prevalent malignant neoplasm worldwide. Iron and copper metabolism disorder regulate ferroptosis and cuproptosis, two forms of cell death, respectively, and play key roles in the progression and treatment response of HNSCC. Recent studies have shown that these two death pathways have complex interactions, which together affect the malignant progression and tolerance of HNSCC, providing potential targets for its treatment. This review systematically elucidates the interconnected regulatory networks linking ferroptosis and cuproptosis in HNSCC, with particular emphasis on the clinical significance of associated biomarkers for diagnosis and therapy. We further discuss the potential advantages of dual-targeting strategies and critically evaluate current challenges and limitations in translational applications. By providing novel insights into metal ion-dependent cell death mechanisms, this review establishes a theoretical foundation for developing innovative combinatorial therapeutic approaches against HNSCC.

## Linked entities

- **Diseases:** Head and Neck Squamous Cell Carcinoma (MONDO:0010150), HNSCC (MONDO:0010150)

## Full-text entities

- **Genes:** ALMS1-IT1 (ALMS1 intronic transcript 1) [NCBI Gene 100874291], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309] {aka BIP, GRP78, HEL-S-89n}, MIR34C (microRNA 34c) [NCBI Gene 407042] {aka MIRN34C, miRNA34C, mir-34c}, ATP7B (ATPase copper transporting beta) [NCBI Gene 540] {aka PWD, WC1, WD, WND}, LIAS (lipoic acid synthetase) [NCBI Gene 11019] {aka HGCLAS, HUSSY-01, LAS, LIP1, LS, PDHLD}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, FGF6 (fibroblast growth factor 6) [NCBI Gene 2251] {aka HBGF-6, HST2}, CBS (cystathionine beta-synthase) [NCBI Gene 875] {aka HIP4}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, ISCA2 (iron-sulfur cluster assembly 2) [NCBI Gene 122961] {aka HBLD1, ISA2, MMDS4, c14_5557}, MIR17HG (miR-17-92a-1 cluster host gene) [NCBI Gene 407975] {aka C13orf25, LINC00048, MIHG1, MIRH1, MIRHG1, NCRNA00048}, FABP5 (fatty acid binding protein 5) [NCBI Gene 2171] {aka E-FABP, EFABP, KFABP, PA-FABP, PAFABP}, REEP6 (receptor accessory protein 6) [NCBI Gene 92840] {aka C19orf32, DP1L1, REEP6.1, REEP6.2, RP77, TB1}, SLC1A5 (solute carrier family 1 member 5) [NCBI Gene 6510] {aka AAAT, ASCT2, ATBO, M7V1, M7VS1, R16}, NTHL1 (nth like DNA glycosylase 1) [NCBI Gene 4913] {aka FAP3, NTH1, OCTS3, hNTH1}, CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1) [NCBI Gene 79094], PRELID2 (PRELI domain containing 2) [NCBI Gene 153768], ANP32B (acidic nuclear phosphoprotein 32 family member B) [NCBI Gene 10541] {aka APRIL, PHAPI2, SSP29}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, LOXL4 (lysyl oxidase like 4) [NCBI Gene 84171] {aka LOXC}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IGF2BP2 (insulin like growth factor 2 mRNA binding protein 2) [NCBI Gene 10644] {aka IMP-2, IMP2, VICKZ2}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, TTC7B (tetratricopeptide repeat domain 7B) [NCBI Gene 145567] {aka TTC7L1, c14_5685}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, DHODH (dihydroorotate dehydrogenase (quinone)) [NCBI Gene 1723] {aka DHOdehase, POADS, URA1}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, PRDX5 (peroxiredoxin 5) [NCBI Gene 25824] {aka ACR1, AOEB166, B166, HEL-S-55, PLP, PMP20}, GABARAPL2 (GABA type A receptor associated protein like 2) [NCBI Gene 11345] {aka ATG8, ATG8C, GATE-16, GATE16, GEF-2, GEF2}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, MT1E (metallothionein 1E) [NCBI Gene 4493] {aka MT-1E, MT-IE, MT1, MTD}, PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) [NCBI Gene 5160] {aka E1alpha, PDHA, PDHAD, PDHCE1A, PHE1A}, LINC01269 (long intergenic non-protein coding RNA 1269) [NCBI Gene 103695436] {aka HNSCAT1, PARLncRNA-1}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, ATP7A (ATPase copper transporting alpha) [NCBI Gene 538] {aka DSMAX, HMNX, MK, MNK, SMAX3}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, KDM4A (lysine demethylase 4A) [NCBI Gene 9682] {aka JHDM3A, JMJD2, JMJD2A, TDRD14A}, KLF5 (KLF transcription factor 5) [NCBI Gene 688] {aka BTEB2, CKLF, IKLF}, TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, MIR148A (microRNA 148a) [NCBI Gene 406940] {aka MIRN148, MIRN148A, hsa-mir-148, mir-148a}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, SCD (stearoyl-CoA desaturase) [NCBI Gene 6319] {aka FADS5, MSTP008, SCD1, SCDOS, hSCD1}, TAGLN (transgelin) [NCBI Gene 6876] {aka SM22, SM22-alpha, SMCC, TAGLN1, TGLN, WS3-10}, UBE2T (ubiquitin conjugating enzyme E2 T) [NCBI Gene 29089] {aka FANCT, HSPC150, PIG50}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, TMEM44-AS1 (TMEM44 antisense RNA 1) [NCBI Gene 100507297], CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, KCNK6 (potassium two pore domain channel subfamily K member 6) [NCBI Gene 9424] {aka K2p6.1, KCNK8, TOSS, TWIK-2, TWIK2}, EMP1 (epithelial membrane protein 1) [NCBI Gene 2012] {aka CL-20, EMP-1, TMP}
- **Diseases:** class III FINs (MESH:D008313), CRGs (MESH:C535507), necrosis (MESH:D009336), FGS (MESH:C537923), esophageal tumor (MESH:D004938), HCC (MESH:D006528), mPT (MESH:D001932), nasopharyngeal carcinoma (MESH:D000077274), glioblastoma (MESH:D005909), copper deficiency (MESH:C535468), mitochondrial fragmentation (MESH:D012892), cytotoxic (MESH:D064420), metastasis (MESH:D009362), anemia (MESH:D000740), CRC (MESH:D015179), Neuroblastoma (MESH:D009447), hypoxia (MESH:D000860), squamous cell carcinoma (MESH:D002294), HNSCC (MESH:D000077195), NPC (MESH:D052556), oral mucosal epithelial dysplasia (MESH:C567703), hypoxic (MESH:D002534), tumorigenesis (MESH:D063646), Cancer (MESH:D009369), fibrosarcoma (MESH:D005354), neurotoxicity (MESH:D020258), ESCC (MESH:D000077277), head and neck cancer (MESH:D006258), erythropoietic disorders (MESH:D017092), iron overload (MESH:D019190), prostate cancer (MESH:D011471), Metal ion homeostasis disorder (MESH:D013651), glioma (MESH:D005910), neurodegenerative diseases (MESH:D019636), PCD (MESH:D007619), PDAC (MESH:C537768), inflammatory (MESH:D007249), MDR (MESH:D018088), mitochondrial damage (MESH:D028361), pancreatic cancer (MESH:D010190)
- **Chemicals:** alcohols (MESH:D000438), Brusatol (MESH:C020237), DTC (MESH:D004050), Baicalin (MESH:C038044), calcium (MESH:D002118), ubiquinol (MESH:C003741), docetaxel (MESH:D000077143), juglone (MESH:C005134), flavonoid (MESH:D005419), GSH (MESH:D005978), capsaicin (MESH:D002211), glutamine (MESH:D005973), B2 (MESH:C023970), ATP (MESH:D000255), polyphenol (MESH:D059808), Plumbagin (MESH:C014758), OH (MESH:C031356), DC (MESH:D003841), cysteine (MESH:D003545), lipid (MESH:D008055), 4-OctylItaconate (MESH:C000708109), gefitinib (MESH:D000077156), NADPH (MESH:D009249), (131) I (MESH:C000614965), TMZ (MESH:D000077204), sulfhydryl (MESH:D013438), VPA (MESH:D014635), TCA (MESH:D014238), CX (MESH:D000068818), curcumin (MESH:D003474), CuET (MESH:C530436), superoxide (MESH:D013481), CeO2@CuO2@DOX (-), Cisplatin (MESH:D002945), H2O2 (MESH:D006861), CFS (MESH:D002142), Erastin (MESH:C477224), cystine (MESH:D003553), TM (MESH:C020809), RGD (MESH:C047981), PC@B (MESH:D011078), atorvastatin (MESH:D000069059), silica (MESH:D012822), DOX (MESH:D004317), PUFAs (MESH:D005231), MOF (MESH:C037042), sorafenib (MESH:D000077157), Copper (MESH:D003300), M1 (MESH:C400939), glutamic acid (MESH:D018698), artemisinin (MESH:C031327), glycine (MESH:D005998), hydroxyl radical (MESH:D017665), -BS (MESH:D001895), aldehydes (MESH:D000447), hyaluronic acid (MESH:D006820), ART (MESH:D000077332), CuCl2 (MESH:C029892), CeO2 (MESH:C030583), tanshinone (MESH:C021751)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Scutellaria baicalensis (Baikal skullcap, species) [taxon 65409]
- **Cell lines:** SSC-25 — Sus scrofa (Pig), Finite cell line (CVCL_A9FM), Cal27 — Homo sapiens (Human), Tongue adenosquamous carcinoma, Cancer cell line (CVCL_1107), CNE-2 — Homo sapiens (Human), Hybrid cell line (CVCL_6889), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946670/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946670/full.md

## References

236 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946670/full.md

---
Source: https://tomesphere.com/paper/PMC12946670